PhoenixBio Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2015
2016
2017
2018
2019
Sales/Revenue
881
1,217
1,229
902
1,228
Cost of Goods Sold (COGS) incl. D&A
273
393
394
402
387
Gross Income
608
824
835
500
842
SG&A Expense
558
634
693
769
1,154
Unusual Expense
-
2
3
-
15
Non Operating Income/Expense
15
39
17
3
32
Interest Expense
3
3
2
2
1
Pretax Income
63
147
130
267
295
Consolidated Net Income
57
125
128
271
297
Net Income
57
125
128
271
297
Net Income After Extraordinaries
57
125
128
271
297
Net Income Available to Common
57
125
128
271
297
EPS (Basic)
22.72
49.32
44.43
93.36
101.96
Basic Shares Outstanding
2
3
3
3
3
EPS (Diluted)
22.72
48.42
44.17
93.36
101.96
Diluted Shares Outstanding
2
3
3
3
3
EBITDA
72
212
167
244
249
Non-Operating Interest Income
-
-
-
9
1
About PhoenixBio Co.
View Profile
